Get the Stockscreener App
3.17
2.92%
0.09
After Hours:
3.17
Cronos Group Inc stock is traded at $3.17, with a volume of 2.03M.
It is up +2.92% in the last 24 hours and up +15.27% over the past month.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
See More
Previous Close:
$3.08
Open:
$3.06
24h Volume:
2.03M
Relative Volume:
1.61
Market Cap:
$1.17B
Revenue:
$159.54M
Net Income/Loss:
$5.06M
P/E Ratio:
-720.45
EPS:
-0.0044
Net Cash Flow:
$26.19M
1W Performance:
+16.54%
1M Performance:
+15.27%
6M Performance:
+23.35%
1Y Performance:
+23.83%
1-Day Range:
$3.04
$3.175
1-Week Range:
$2.902
$3.175
52-Week Range:
$2.28
$3.43
Cronos Group Inc Stock (CRON) Company Profile
Name
Cronos Group Inc
Sector
Phone
(416) 504-0004
Address
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRON
Cronos Group Inc
|
3.17 | 1.13B | 159.54M | 5.06M | 26.19M | -0.0044 |
TAK
Takeda Pharmaceutical Co Adr
|
17.41 | 55.82B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.80 | 43.73B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.74 | 42.51B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
73.54 | 31.14B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
511.72 | 22.11B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-28-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-11-22 | Upgrade | CIBC | Neutral → Sector Outperform |
| Mar-22-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-27-22 | Upgrade | Jefferies | Underperform → Hold |
| Nov-18-21 | Resumed | BofA Securities | Underperform |
| Apr-28-21 | Resumed | BofA Securities | Underperform |
| Feb-22-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-24-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-27-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-14-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-02-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-31-20 | Downgrade | Canaccord Genuity | Hold → Sell |
| Mar-04-20 | Upgrade | MKM Partners | Neutral → Buy |
| Mar-03-20 | Downgrade | Stifel | Buy → Hold |
| Oct-18-19 | Upgrade | Stifel | Hold → Buy |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-05-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Aug-13-19 | Initiated | Piper Jaffray | Overweight |
| Aug-09-19 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-28-19 | Initiated | Consumer Edge Research | Equal Weight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Upgrade | BofA/Merrill | Underperform → Buy |
| Apr-17-19 | Initiated | BofA/Merrill | Underperform |
| Mar-27-19 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-25-19 | Initiated | Jefferies | Underperform |
| Jan-18-19 | Initiated | CIBC | Sector Outperform |
View All
Cronos Group Inc Stock (CRON) Latest News
Could Cronos Group (TSX:CRON) Be Canada’s Next Growth Stock? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) on Watch as Dow Trades Mixed? - Kalkine Media
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Cronos Group (NASDAQ:CRON) the Cannabis Name Drawing Notice This Season - Kalkine Media
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Why Trump Media Stock Just Sank 9.4% - The Motley Fool
Why Cronos Group (NASDAQ:CRON) Keeps Building Global Cannabis Brand Reach? - Kalkine Media
Cronos Group (CRON) Institutional Ownership 2026 $CRON - MarketBeat
Cronos Group (NASDAQ:CRON): Can Brand Demand Strengthen? - Kalkine Media
TSX Value Stock Estimates Featuring Cronos Group And 2 More - webull.com
Cronos Group (TSX:CRON) Is Up 6.4% After Swinging Back To Profit And Beating Q2 Expectations - webull.com
Cronos Group Inc. 8-K/A Filing Confirms Annual Say-on-Pay Votes for Shareholders - Minichart
Deferred share unit grant for Cronos Group Inc. (CRON) director Garnick - Stock Titan
Director grant at Cronos Group Inc. (CRON) adds deferred share units - Stock Titan
Cronos Group Inc. (CRON) director receives deferred share unit award - Stock Titan
Cronos Group (NASDAQ:CRON) Brand Growth & Market Expansion Update - Kalkine Media
Cronos Group Inc (CRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts (NASDAQ:CRON) - Seeking Alpha
Why Cronos Group (NASDAQ:CRON) Is The Talk Of The Cannabis Sector Today? - Kalkine Media
Cronos Group expands in Europe with strong Q2 g... - Pluang
Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A - Seeking Alpha
Cronos Group Stock Surges 13.68% as Cannabis Market Optimism and International Growth Spark Investor Interest - kalkine.ca
Why Has Cronos Group (TSX:CRON) Regained Market Spotlight Again? - Kalkine Media
CRON SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fil - GuruFocus
Cronos Group Inc. (CRON) Stock Analysis: Navigating a 40% Revenue Growth with Investor Ratings in Focus - DirectorsTalk Interviews
Cronos Group (NASDAQ:CRON): What Should Readers Watch Around Friday’s New Company Catalyst? - Kalkine Media
Cronos Group Inc (CRON) (Q2 2026) Earnings Call Highlights: Reco - GuruFocus
Cronos Group Inc. Reports Strong Q2 2026 Financial Results: Earnings, Revenue & Comprehensive Income Highlights - Minichart
Why Cronos Group (TSX:CRON) Is Up 6.4% After Swinging To US$32 Million Quarterly Profit - finance.yahoo.com
Cronos Group Inc. stock rises Thursday, outperforms market - MarketWatch
Cronos Group (TSX:CRON) Expands Global Cannabis Strategy With Financial Strength - Kalkine Media
Cronos Group Announces Strong Q2 2026 Financial Performance with Increased Revenue and Operating Profit - Kalkine Media
Cannabis Stocks To Watch NowAugust 6th - MarketBeat
Cronos Group Q2 Earnings Call Highlights - finance.yahoo.com
Cronos Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Is Cronos Group Inc (CRON) Undervalued After Q2 Earnings Beat wi - GuruFocus
Cronos Group Shares Rise After Swing to Q2 Earnings, Higher Revenue - marketscreener.com
Cronos Group (NASDAQ:CRON) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Stocks in play: Cronos Group Inc. - The Globe and Mail
Earnings call transcript: Cronos Group posts Q2 2026 beat, shares jump 13.2% - Investing.com
Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates - finance.yahoo.com
Cronos Group Reports Record Q2 2026 Revenue of $53 Million - StratCann
Cronos stock jumps after Q2 beat (CRON:NASDAQ) - Seeking Alpha
Earnings Flash (CRON) Cronos Group Inc. Reports Q2 Revenue $53.0M, vs. FactSet Est of $44.2M - marketscreener.com
Cronos Group posts record Q2 2026 revenue and p... - Pluang
Canada's Cronos Group Q2 revenue beats estimates on higher cannabis flower sales - TradingView
Cronos Q2 revenue rises 58% to $53 million as profit returns - Quiver Quantitative
Cronos Group (Nasdaq: CRON) swings to profit and launches new share repurchase plan - Stock Titan
Cronos Group reports Q2 2026: Net revenue $53.0M, gross profit $28.5M, adjusted EBITDA $13.1M - TradingView
Tranche Update on Cronos Group Inc.'s Equity Buyback Plan announced on May 8, 2025. - marketscreener.com
BRIEF-Cronos Group Q2 Gross Profit USD 28.5 Million - TradingView
Cronos Group Inc Stock (CRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.17%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):